QV Bioelectronics
Medical device company developing an innovative electrotherapy implant for the treatment of glioblastoma patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
* | £860k | Grant | |
| Total Funding | 000k | ||
Related Content
QV Bioelectronics is a pioneering medical technology startup focused on developing advanced electrotherapy devices for the treatment of brain tumours, specifically glioblastoma. The company operates in the healthcare and medical device market, targeting hospitals, clinics, and medical research institutions as its primary clients. QV Bioelectronics employs a business model that combines research and development with clinical trials to bring its innovative products to market. Revenue is generated through the sale of these medical devices, as well as potential partnerships and licensing agreements with larger healthcare companies. The startup leverages its expertise in bioelectronics to offer a novel approach to cancer treatment, aiming to improve patient survival rates and quality of life.
Keywords: bioelectronics, electrotherapy, brain tumours, glioblastoma, medical devices, healthcare, innovation, clinical trials, patient outcomes, cancer treatment.